View in EDS HTML Full Text PDF Full Text

BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways.

Saved in:

Bibliographic Details
Title:	BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways.
Authors:	Zhang, Yang^1,2 (AUTHOR), Xu, Bingwei¹ (AUTHOR), Shi, Junfeng³ (AUTHOR), Li, Jieming^1,4 (AUTHOR), Lu, Xinlan⁵ (AUTHOR), Xu, Li⁶ (AUTHOR), Yang, Helen¹ (AUTHOR), Hamad, Nevean¹ (AUTHOR), Wang, Chi¹ (AUTHOR), Napier, Dana¹ (AUTHOR), He, Shuixiang⁵ (AUTHOR), Liu, Chunming¹ (AUTHOR), Liu, Zeyi² (AUTHOR), Qian, Hai⁴ (AUTHOR), Chen, Li¹ (AUTHOR), Wei, Xiaowei³ (AUTHOR), Zheng, Xucai⁷ (AUTHOR), Huang, Jian-An² (AUTHOR), Thibault, Olivier¹ (AUTHOR), Craven, Rolf¹ (AUTHOR)
Source:	Cellular Oncology (2211-3428). 2020, Vol. 43 Issue 6, p1049-1066. 18p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!